NAIROBI, Kenya- Mbagathi County Referral Hospital has expanded its diabetes clinic from two days a week to five as Nairobi steps up efforts to identify the condition early and improve access to long-term care.
The expanded service was announced during a World Diabetes Day event held in partnership with Nairobi City County and healthcare company Novo, where up to 400 community members were expected to receive free screening and health services.
The initiative, held under the 2026 theme, Early Action on Diabetes, offered diabetes and hypertension screening, HbA1c testing, eye and foot checks, as well as HIV and tuberculosis screening.
Participants also received nutrition education, took part in a physiotherapist-led physical activity demonstration and joined discussions on diabetes prevention, diagnosis and day-to-day management.
More clinic days for patients
The hospital’s dedicated diabetes clinic will now operate from Monday to Friday through its Centre for Driving Change in Diabetes, increasing access for patients who previously relied on a mixed clinic that ran only twice a week.
Mbagathi attends to an estimated 250 to 300 diabetes patients every month. The clinic accepts walk-in patients, while eligible people living with Type 1 diabetes and aged below 25 can receive insulin support.
The hospital formally launched its Comprehensive Diabetes Centre in September through the iCARE partnership involving Mbagathi, Nairobi City County and Novo.
The facility was designed to provide clinical care alongside nutrition counselling, patient education and self-management support.
Dr Erica Koima, Mbagathi Hospital’s Medical Superintendent, speaking on behalf of Chief Executive Officer Dr Alexander Irungu, said the extended clinic hours would help patients access care more consistently.
“Behind every patient attended to is a life being supported, a family being given hope and a complication potentially being prevented,” Dr Koima said.
Closing the diagnosis gap
Jakob Mollerup, Novo’s General Manager for Middle Africa, said more than 800,000 people in Kenya were living with diabetes, with over half believed to be unaware of their condition because they had not been diagnosed.
He said the focus should go beyond awareness campaigns to include trained health workers, accessible services and continued patient support.
Novo said its iCARE programme has established more than 92 Centres for Driving Change in Diabetes across Kenya, trained over 3,500 healthcare professionals and supported more than 6,100 people to access affordable insulin.
“Early action speaks directly to the need for early diagnosis, early treatment and good-quality care,” Mollerup said.
“It is important that people are reached earlier, that they understand their condition and that they can access the support they need to manage it.”
Dr Moses Owino, the County Director of Medical Services, said diabetes action must continue beyond commemorative events through regular screening, healthier lifestyles and uninterrupted, patient-centred care.
Screening before complications develop
World Health Organization data shows that more than 40% of people living with diabetes globally are undiagnosed.
The agency says increased thirst, frequent urination, unexplained weight loss, tiredness and blurred vision can be warning signs that require medical advice.
Dr Florence Keli of the Kenya Diabetes Study Group urged people to check their blood sugar regularly, especially as they grow older, and advised those diagnosed with diabetes to continue their prescribed treatment and clinical follow-up.
People living with diabetes also shared their experiences at the event.
Eric Omondi, who has lived with Type 1 diabetes for 23 years, said diagnosis should not be viewed as the end of a person’s aspirations.
“With the right information, treatment and support, people living with diabetes can lead fulfilling and productive lives,” he said.
Fred Momanyi, who has lived with Type 2 diabetes for 13 years, encouraged Kenyans to seek screening before complications emerge.
The partners said the focus now is on sustaining screening, treatment and follow-up services, so that people at risk know their status early and those already diagnosed can receive continuous care.




